Nephrotic Syndrome
📧 Sign up to get email alerts when something new happens for Nephrotic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Immune System Related Kidney Disease
A National Institute of Diabetes and Digestive and Kidney Diseases-sponsored clinical trial investigating immune system-related kidney disea…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy [Phase 2]
A Phase 2 trial evaluating rituximab plus cyclosporine for idiopathic membranous nephropathy is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Multitarget Strategy for Primary Podocytopathies [NA]
Clinical trial update on a multitarget strategy for primary podocytopathies in nephrotic syndrome. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria [Phase 2]
A Phase 2 clinical trial is evaluating AP1189 in patients with idiopathic membranous nephropathy who have nephrotic syndrome or severe prote…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequent Relapses or Steroid Dependence [Phase 2]
Phase 2 trial evaluating SG301, a CD38-targeting monoclonal antibody, given subcutaneously in children with nephrotic syndrome who have freq…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Belimumab With Rituximab for Primary Membranous Nephropathy [Phase 2]
Phase 2 clinical trial evaluating the combination of belimumab with rituximab for primary membranous nephropathy is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Study of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome [NA]
A clinical trial update for ripertamab in children with frequent relapses or steroid-dependent nephrotic syndrome; the study is not yet recr…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease [Phase 1]
Phase 1 clinical trial update for a CAR T-cell therapy targeting CD19 and BCMA in autoimmune conditions, with recruiting status and potentia…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome [Phase 2, Phase 3]
Clinical trial update on the use of SGLT2 inhibitors for adult primary nephrotic syndrome, covering Phase 2 and Phase 3, sponsored by Mansou…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Atacicept in Multiple Glomerular Diseases [Phase 2]
Phase 2 clinical trial evaluating atacicept in multiple glomerular diseases is currently recruiting, including primary membranous nephropath…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
This clinical trial update describes an interview study of adult and pediatric patients with swelling due to nephrotic syndrome and of paren…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Dupilumab Therapy in Nephrotic Syndrome in Children [Phase 2]
The document describes a Phase 2 clinical trial evaluating dupilumab for nephrotic syndrome in children, including steroid-dependent nephrot…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: The Role of Vitamin K2 in Preventing Glucocorticoid-Induced Bone Loss in Children With Nephrotic Syndrome [NA]
A clinical trial sponsored by Ain Shams University is evaluating whether Vitamin K2 can prevent glucocorticoid-induced bone loss in children…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Diuretic Tuner Clinical Decision Support [NA]
A clinical trial update indicates that a Diuretic Tuner Clinical Decision Support tool is currently recruiting at UT Southwestern Medical Ce…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: The Role of Proprotein-convertase-subtilisin/Kexin-type 9 in Kidney Damage in Nephrotic Syndrom
This clinical trial update describes an ongoing study evaluating the role of PCSK9 in kidney damage within nephrotic syndrome and notes that…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Comparing the Performance of Serum Creatinine and Cystatin C-based GFR Estimations in Predicting Directly Measured GFR in Patients With or Without Nephrotic Syndrome
This clinical trial update compares serum creatinine- and cystatin C-based GFR estimations with directly measured GFR in patients with and w…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS [Phase 1]
Phase 1 clinical trial evaluating CAR-T cell therapy for multi-drug resistant nephrotic syndrome, currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome [NA]
This clinical trial entry describes a study of steady-state pharmacokinetics and pharmacodynamics of edoxaban in adults with nephrotic syndr…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Blinatumomab for CNI-Resistant/Intolerant SRNS in Children [Phase 1]
Phase 1 trial evaluating blinatumomab for children with calcineurin inhibitor–resistant or intolerant steroid-resistant nephrotic syndrome; …
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: The Selection of Initial Treatment Regimens for Adolescent Nephrotic Syndrome.
This clinical trial update outlines the selection of initial treatment regimens for adolescents with nephrotic syndrome and indicates the st…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
A clinical trial update from Assistance Publique - Hôpitaux de Paris describes a study on epithelial dysmetabolism and renal fibrosis in ANC…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS [Phase 1]
A Phase 1 clinical trial evaluating anti-CD19 CAR-T cell therapy for multidrug-resistant steroid-resistant nephrotic syndrome is currently r…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome [Phase 3]
Phase 3 clinical study evaluating Rituximab for idiopathic membranous nephropathy with nephrotic syndrome is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study
Pediatric nephrotic syndrome study aiming to identify biomarkers and outcome predictors through genetic, transcriptomic, and secretome multi…
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure
ClinicalTrials.gov update describes a study on genetic causes of focal segmental glomerulosclerosis, nephrotic syndrome, and related kidney …